FDA Person
FDANina Yang
View detailed information about Nina Yang, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 46 inspections of 43 companies, 2016–2026.
Inspections (46)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 25, 2026 | Zydus Pharmaceuticals (USA) Inc | Not classified | #1304142 | |
| September 11, 2026 | Incyte Corporation | Not classified | #1337612 | |
| August 19, 2026 | GSK LLC (GlaxoSmithKline) | Not classified | #1318026 | |
| September 20, 2019 | Arjun Vasant Balar, M.D. | NAI | Bioresearch Monitoring | #1105236 |
| September 3, 2019 | William J. Long, M.D. | NAI | Bioresearch Monitoring | #1101601 |
| August 2, 2019 | Amarin Pharma Inc. | NAI | Bioresearch Monitoring | #1100373 |
| July 2, 2019 | Novartis Pharmaceuticals Corporation | VAI | Bioresearch Monitoring | #1094986 |
| May 22, 2019 | SK Life Science Inc. | VAI | Bioresearch Monitoring | #1090433 |
| April 15, 2019 | Appco Pharma, LLC | VAI | Postmarket Surv. and Epidemiology | #1086303 |
| March 8, 2019 | SUN PHARMACEUTICAL INDUSTRIES INC | NAI | Bioresearch Monitoring | #1083409 |
| February 8, 2019 | Mallinckrodt Hospital Products Inc. | NAI | Bioresearch Monitoring | #1080926 |
| January 25, 2019 | Lucasti Christopher, D.O. | NAI | Bioresearch Monitoring | #1079073 |
| December 4, 2018 | Edmund Claxton, MD | NAI | Bioresearch Monitoring | #1073398 |
| December 4, 2018 | Robert J. Weiss, M.D. | NAI | Bioresearch Monitoring | #1073394 |
| November 1, 2018 | Roberta R. Ball, D.O. | NAI | Bioresearch Monitoring | #1070567 |
| October 5, 2018 | Pfizer, Inc. | NAI | Bioresearch Monitoring | #1070712 |
| September 25, 2018 | Virtua IRB | NAI | Bioresearch Monitoring | #1081934 |
| September 7, 2018 | HQ Specialty Pharma | NAI | Bioresearch Monitoring | #1067103 |
| August 6, 2018 | Rowan University School of Osteopathic Medicine IRB | NAI | Bioresearch Monitoring | #1063952 |
| July 18, 2018 | Vertical Pharmaceuticals, LLC | VAI | Bioresearch Monitoring | #1059217 |
Documents (17)
- EIR · Dr. Reddy's Laboratories, Inc. · February 7, 2020
- 483 · Eisai, Inc. · February 16, 2018
- EIR · Bristol-Myers Squibb Company · June 3, 2020
- 483 · Merck & Co. Inc · August 26, 2016
- 483 · Appco Pharma, LLC · April 15, 2019
- EIR · Merck & Company · January 20, 2021
- EIR · inVentiv Health Clinical Lab, Inc. · November 8, 2019
- EIR · Novartis Pharmaceuticals Corporation · September 7, 2017
- EIR · Novartis Pharmaceuticals Corporation · January 24, 2017
- 483 · Steven David, M.D. · January 8, 2018
- 483 · Insmed, Inc. · August 3, 2021
- 483 · Sanofi US · August 3, 2016
- 483 · Novartis Pharmaceuticals Corporation · July 2, 2019
- 483 · Robert S. Falcone, M.D. · April 5, 2021
- 483 · Merck & Company · January 20, 2021
- 483 · Novartis Pharmaceuticals Corporation · January 24, 2017
- EIR · David R. Hassman, DO · September 27, 2017
Frequently inspected with (10)
Shirley S. Wen
8 shared
Peter R. Lenahan
Regulatory Officer
7 shared
Michael Serrano
investigator
4 shared
Anastasia I. Onuorah
investigator
2 shared
Barbara J. Maulfair
investigator
1 shared
Bei Yu
issuing_officer
1 shared
Byungja E. Marciante
1 shared
Cheryl A. Grandinetti
investigator
1 shared
Jean M. Mulinde
1 shared
Lauren C. Iacono-Connors
1 shared
Person Information
Name
Nina Yang
Title
investigator
Role
COMPANY REP
ID: 8d080437-2e05-4b75-8c53-b818d761cf1f
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.